Strong Q3 performance and a steady pipeline of new launches are expected to support Sun Pharma's growth outlook, with ...

Aucta Pharmaceuticals is pleased to announce the late January launch of PYQUVI oral suspension 22.75 mg/mL. PYQUVI, a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in ...

Global pharmaceutical company Merck (NYSE:MRK) announced better-than-expected revenue in Q4 CY2025, with sales up 5% year on ...

Product is currently under review with the FDAPotential approval and launch mid-2026DEER PARK, Ill., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Eton ...

Indian drugmaker Alembic Pharmaceuticals on Thursday reported lower third‑quarter profit on Thursday after taking a one-time charge linked to India's new ‍labour code, despite strong demand for its ...

Oncoscope launches the first Real-time, AI-supported Living Systematic Literature Review designed for enterprise-wide ...

India’s largest drug-maker Sun Pharmaceutical Industries posted a 16 per cent year-on-year (Y-o-Y) growth in its consolidated ...

For the better part of a year, Merck & Co. and Halozyme have been locked in an intellectual property disagreement over the the pharma giant's new, under-the-skin version of cancer megablockbuster ...

What's the role of the marketing department as a pharma product moves through the process of development up to launch? That was a major topic during a recent Beghou Consulting webinar. As pharma ...

Q4 2025 Management View CEO Stephan Tanda emphasized "very strong top line performance" for Q4, with reported sales growing 14% to $963 million and core sales up 5%. Tanda noted, "Adjusted EBITDA ...